Researchers studied 683 breast cancer patients’ preferences for involvement in treatment decision-making. They found that before consultation, most patients preferred shared or patient-directed treatment decision-making. Post-consultation, however, 43 percent of patients’ preferences changed — most changes indicated a preference for patient-directed decisions. Patients who were as involved as they wanted to be or were more involved than they wanted had significantly better decision-related outcomes than patients who were not as involved.
The authors said oncologists should encourage cancer patients to participate in treatment decision-making.
Related Articles on Hospital Oncology:
Ben Venue Laboratories Releases Limited Supply of Cancer Drug to Ease Shortage
CentraState Healthcare in New Jersey Opens $10M Radiation Oncology Suite
Kimmel Cancer Center at Jefferson in Philadelphia Creates Center to Eliminate Cancer Disparities
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
